142 related articles for article (PubMed ID: 11120822)
1. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease.
Webb CF; Yamashita Y; Ayers N; Evetts S; Paulin Y; Conley ME; Smith EA
J Immunol; 2000 Dec; 165(12):6956-65. PubMed ID: 11120822
[TBL] [Abstract][Full Text] [Related]
2. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.
Rawlings DJ; Saffran DC; Tsukada S; Largaespada DA; Grimaldi JC; Cohen L; Mohr RN; Bazan JF; Howard M; Copeland NG
Science; 1993 Jul; 261(5119):358-61. PubMed ID: 8332901
[TBL] [Abstract][Full Text] [Related]
3. Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.
Rajaiya J; Hatfield M; Nixon JC; Rawlings DJ; Webb CF
Mol Cell Biol; 2005 Mar; 25(6):2073-84. PubMed ID: 15743806
[TBL] [Abstract][Full Text] [Related]
4. Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I.
Rajaiya J; Nixon JC; Ayers N; Desgranges ZP; Roy AL; Webb CF
Mol Cell Biol; 2006 Jun; 26(12):4758-68. PubMed ID: 16738337
[TBL] [Abstract][Full Text] [Related]
5. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.
Novina CD; Kumar S; Bajpai U; Cheriyath V; Zhang K; Pillai S; Wortis HH; Roy AL
Mol Cell Biol; 1999 Jul; 19(7):5014-24. PubMed ID: 10373551
[TBL] [Abstract][Full Text] [Related]
6. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.
Anderson JS; Teutsch M; Dong Z; Wortis HH
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10966-71. PubMed ID: 8855292
[TBL] [Abstract][Full Text] [Related]
7. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
Mizuno T; Rothstein TL
J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells.
Nixon JC; Ferrell S; Miner C; Oldham AL; Hochgeschwender U; Webb CF
J Immunol; 2008 Nov; 181(10):6913-22. PubMed ID: 18981111
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor, Bright, and immunoglobulin heavy chain expression.
Webb CF
Immunol Res; 2001; 24(2):149-61. PubMed ID: 11594453
[TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation.
Bajpai UD; Zhang K; Teutsch M; Sen R; Wortis HH
J Exp Med; 2000 May; 191(10):1735-44. PubMed ID: 10811866
[TBL] [Abstract][Full Text] [Related]
12. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
Petro JB; Rahman SM; Ballard DW; Khan WN
J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867
[TBL] [Abstract][Full Text] [Related]
13. xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.
Cancro MP; Sah AP; Levy SL; Allman DM; Schmidt MR; Woodland RT
Int Immunol; 2001 Dec; 13(12):1501-14. PubMed ID: 11717191
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells.
Mahajan S; Vassilev A; Sun N; Ozer Z; Mao C; Uckun FM
J Biol Chem; 2001 Aug; 276(33):31216-28. PubMed ID: 11413148
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity to transforming growth factor (TGF)-beta of CBA and of CBA/N B cells demonstrates that the IgG2b inducing factor in synovial fluid from rheumatoid arthritis patients is not identical to TGF-beta.
Ridderstad A; Lettesjö H; Abedi-Valugerdi M; Möller E
Int Immunol; 1995 Mar; 7(3):459-69. PubMed ID: 7794824
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations.
Nixon JC; Rajaiya JB; Ayers N; Evetts S; Webb CF
Cell Immunol; 2004 Mar; 228(1):42-53. PubMed ID: 15203319
[TBL] [Abstract][Full Text] [Related]
18. Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation.
Vinuesa CG; Sunners Y; Pongracz J; Ball J; Toellner KM; Taylor D; MacLennan IC; Cook MC
Eur J Immunol; 2001 May; 31(5):1340-50. PubMed ID: 11465091
[TBL] [Abstract][Full Text] [Related]
19. Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright.
Schmidt C; Kim D; Ippolito GC; Naqvi HR; Probst L; Mathur S; Rosas-Acosta G; Wilson VG; Oldham AL; Poenie M; Webb CF; Tucker PW
EMBO J; 2009 Mar; 28(6):711-24. PubMed ID: 19214191
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
